Loading...

PE anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
a-30-F11_PE_090507
C57BL/6 mouse splenocytes stained with 30-F11 PE
  • a-30-F11_PE_090507
    C57BL/6 mouse splenocytes stained with 30-F11 PE
  • b-30-F11_PE_CD45_Antibody_2_041922
    C57BL/6 mouse splenocytes were stained with CD45 (clone 30-F11) PE (solid line) or rat IgG2b, κ PE isotype control (dashed line).

    Data was acquired on the Moxi Flow, exported, and processed using FlowJo software.
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
103105 50 µg £31
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103106 200 µg £59
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Linden J, et al. 2020. J Interferon Cytokine Res. 40:292. PubMed
  2. Ramos SA, et al. 2022. J Allergy Clin Immunol. 149:767. PubMed
  3. Friesen M, et al. 2022. Brain Pathol. 32:e13032. PubMed
  4. Kang H, et al. 2022. Adv Mater. 34:e2106500. PubMed
  5. Brandt KJ, et al. 2022. Int J Mol Sci. 23: . PubMed
  6. Cha JH, et al. 2022. J Biol Chem. 298:101817. PubMed
  7. Cox MJ, et al. 2022. Leukemia. 36:1635. PubMed
  8. Yu C, et al. 2022. Invest Ophthalmol Vis Sci. 63:1. PubMed
  9. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  10. Liu X, et al. 2022. Chin Med J (Engl). 135:1821. PubMed
  11. Zhang X, et al. 2022. EBioMedicine. 84:104275. PubMed
  12. Dedousis N, et al. 2022. J Lipid Res. 63:100284. PubMed
  13. Yang J, et al. 2022. Mol Ther Nucleic Acids. 30:184. PubMed
  14. Hirano K, et al. 2023. Life Sci Alliance. 6: . PubMed
  15. Ding L, et al. 2023. J Clin Invest. 133: . PubMed
  16. Al-Saafeen BH, et al. 2023. Front Immunol. 13:1017780. PubMed
  17. Montilla A, et al. 2023. Cell Death Dis. 14:16. PubMed
  18. Smith LA, et al. 2023. Front Oncol. 12:1031174. PubMed
  19. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  20. Wang Y, et al. 2023. FASEB J. 37:e22776. PubMed
  21. Tanaka T, et al. 2023. Nat Immunol. 24:439. PubMed
  22. Wang R, et al. 2023. iScience. 26:105954. PubMed
  23. Vuerich R, et al. 2023. NPJ Regen Med. 8:8. PubMed
  24. Tan Y, et al. 2023. NPJ Regen Med. 8:7. PubMed
  25. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  26. Frieler RA, et al. 2017. Exp Neurol. 298:104. PubMed
  27. Djokić V, et al. 2019. Front Immunol. 9:2891. PubMed
  28. Hepler C et al. 2017. eLife. 6 pii: e27669. PubMed
  29. Chan LC, et al. 2019. J Clin Invest. 129:3324. PubMed
  30. Khorooshi R, et al. 2020. Acta Neuropathol Commun. 8:02. PubMed
  31. Kimura S, et al. 2020. Nat Commun. 0.620833333. PubMed
  32. Kretschmer I, et al. 2016. J Biol Chem. 291: 4091 - 4106. PubMed
  33. Moreno-García Á, et al. 2020. Biomolecules. 10:00. PubMed
  34. Liu K, et al. 2021. Cell Metabolism. 33(3):666-675.e4. PubMed
  35. Vercauteren Drubbel A, et al. 2021. Cell Stem Cell. . PubMed
  36. Masuda H, et al. 2022. MAbs. 14:2122275. PubMed
  37. Shi H, et al. 2022. Nutrients. 14:. PubMed
  38. Peng W, et al. 2022. Cell Mol Life Sci. 79:602. PubMed
  39. Elbasiony E, et al. 2023. NPJ Aging. 9:2. PubMed
  40. Pioli KT, et al. 2023. iScience. 26:106223. PubMed
  41. Dang YZ, et al. 2023. Neoplasma. 70:123. PubMed
  42. Palakurthi B, et al. 2023. Nat Commun. 14:2109. PubMed
  43. Shen Z, et al. 2023. iScience. 26:106572. PubMed
  44. Abdelwahab T, et al. 2023. iScience. 26:106698. PubMed
  45. Xin G, et al. 2021. Cancer Immunol Res. 9:454. PubMed
  46. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  47. d'Errico P, et al. 2021. Nat Neurosci. Online ahead of print. PubMed
  48. Afolabi LO, et al. 2021. Front Immunol. 12:701671. PubMed
  49. Hagan N, et al. 2020. Cell Death Dis. 1.086111111. PubMed
  50. Giorgetti E, et al. 2020. Cell Reports. 29(6):1539-1554.e7.. PubMed
  51. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  52. Abels ER et al. 2019. Cell Rep. 28(12):3105-3119 . PubMed
  53. Sun D, et al. 2021. Cell Stem Cell. . PubMed
  54. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  55. Weng L, et al. 2016. Sci Rep. 6:38632. PubMed
  56. Chen J, et al. 2021. Sci Adv. 7:. PubMed
  57. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  58. Karlen SJ, et al. 2018. J Neuroinflammation. 15:344. PubMed
  59. Cieslik KA, et al. 2018. J Gerontol A Biol Sci Med Sci. 73:1167. PubMed
  60. Kobayashi Y, et al. 2018. PLoS One. 13:e0195008. PubMed
  61. Riley JS, et al. 2020. Blood Adv. 4:1102. PubMed
  62. Maimets M, et al. 2016. Stem Cell Reports. 6:150-162. PubMed
  63. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  64. Tilstam PV, et al. 2021. J Clin Invest. 131:. PubMed
  65. Catrina AM, et al. 2021. Rom J Morphol Embryol. 62:109. PubMed
  66. Wei H, et al. 2020. Cell Death Dis. 11:290. PubMed
  67. Ogawa M, et al. 2019. J Biol Methods. 5:e102. PubMed
  68. Shmeleva EV, et al. 2019. Front Immunol. 10:1780. PubMed
  69. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  70. Fan C, et al. 2020. Stem Cell Res Ther. 0.765277778. PubMed
  71. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  72. Wang Y, et al. 2021. Nat Commun. 12:2343. PubMed
  73. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  74. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  75. Sun Q, et al. 2022. Cell Death Dis. 13:724. PubMed
  76. Galle E, et al. 2022. Genome Biol. 23:207. PubMed
  77. Verma M, et al. 2018. Brain Behav Immun. 69:223. PubMed
  78. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  79. Rafiq S, et al. 2018. Nat Biotechnol. 36:847. PubMed
  80. Aoki H, et al. 2009. Development. 136:2511. PubMed
  81. Guha S, et al. 2014. Brain Behav Immun. 11:123. PubMed
  82. Serrano Martinez P, et al. 2022. iScience. 25:105047. PubMed
  83. Ogawa-Wong A, et al. 2022. Metabolites. 12:. PubMed
  84. Hongu T, et al. 2022. Nat Cancer. 3:486. PubMed
  85. An YA et al. 2017. eLife. 6 pii: e24071. PubMed
  86. Meixiong J et al. 2019. Immunity. 50(5):1163-1171 . PubMed
  87. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  88. Hsu JM, et al. 2018. Nat Commun. 9:1908. PubMed
  89. Endo Y, et al. 2020. FASEB J. 34:16086. PubMed
  90. An J, et al. 2022. iScience. 25:103570. PubMed
  91. Shen Y, et al. 2022. CNS Neurosci Ther. 28:46. PubMed
  92. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  93. Green DP, et al. 2019. Neuron. 101:412. PubMed
  94. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  95. Vijay R, et al. 2015. J Exp Med. 212: 1851 - 1868. PubMed
  96. Dumas AA, et al. 2020. EMBO J. 39:e103790. PubMed
  97. Fontana D, et al. 2020. Hemasphere. e497:4. PubMed
  98. Ye Z, et al. 2019. Mediators Inflamm. 2019:8709583. PubMed
  99. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  100. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  101. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  102. Marinescu CI, et al. 2021. Stem Cell Res Ther. 12:319. PubMed
  103. Chang CS, et al. 2022. iScience. 25:103738. PubMed
  104. Sinha VC, et al. 2021. Nat Commun. 12:5024. PubMed
  105. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  106. Hu J, et al. 2022. J Neuroinflammation. 19:71. PubMed
  107. Slezak AJ, et al. 2022. ACS Cent Sci. 8:1435. PubMed
  108. Yu Y, et al. 2022. Nat Commun. 13:6857. PubMed
  109. Sardella C, et al. 2018. J Invest Dermatol. 138:500. PubMed
  110. Yee PP, et al. 2020. Nat Commun. 4.225. PubMed
  111. Oliver J, et al. 2009. J Am Soc Nephrol. 2.440972222. PubMed
  112. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  113. Yang Z, et al. 2020. Sci Rep. 17757:10. PubMed
  114. Socodato R, et al. 2020. Sci Signal. 13: . PubMed
  115. Bauer T, et al. 2021. Life (Basel). 11:. PubMed
  116. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  117. Ebrahimi-Nik H, et al. 2021. Nat Commun. 12:6423. PubMed
  118. Khatib–Massalha E, et al. 2020. Nat Commun. 2.921527778. PubMed
  119. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  120. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  121. Ito T, et al. 2021. Commun Biol. 4:694. PubMed
  122. Fang Y, et al. 2019. Aging (Albany NY). 11:4910. PubMed
  123. Wilson DH, et al. 2020. Nat Commun. 0.767361111. PubMed
  124. Olson M, et al. 2014. J Immunol. 193:5420. PubMed
  125. Barker KA, et al. 2021. Journal of Clinical Investigation. 131(11):. PubMed
  126. Sun H, et al. 2022. Front Immunol. 13:818017. PubMed
  127. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  128. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  129. Wang QA et al. 2018. Cell metabolism. 28(2):282-288 . PubMed
  130. Khare P, et al. 2017. J Autoimmun. 10.1016/j.jaut.2017.09.002. PubMed
  131. Feng J,et al. 2017. Nat Commun. . 10.1038/s41467-017-01056-8. PubMed
  132. Douam F, et al. 2017. Mbio. 10.1128/mBio.00819-17. PubMed
  133. Liu X, et al. 2020. Cell Host Microbe. 28(5):683-698.e6. PubMed
  134. Walsh SM, et al. 2021. eLife. 10:00. PubMed
  135. Madenspacher JH, et al. 2020. JCI Insight. 5:00. PubMed
  136. Meng X, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  137. Hu M, et al. 2020. Cancer Immunol Res. 8:1150. PubMed
  138. Kitajima Y, et al. 2022. Cells. 11:. PubMed
  139. Li Y, Kaneda T 2016. Sci Rep. 6: 25077. PubMed
  140. Wijewarnasuriya D, et al. 2020. Cancer Immunol Res. 0.841666667. PubMed
  141. Bota-Rabassedas N, et al. 2021. Cell Reports. 35(3):109009. PubMed
  142. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  143. McCallion A, et al. 2022. Front Immunol. 13:961599. PubMed
  144. Matsumoto A, et al. 2021. iScience. 24:102839. PubMed
  145. Lee-Chang C, et al. 2021. J Exp Med. 218:. PubMed
  146. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  147. Senthil K, et al. 2021. Invest Ophthalmol Vis Sci. 62:38. PubMed
  148. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  149. Kamata T, et al. 2020. Cell Reports. 31(12):107802. PubMed
  150. Dhar P, et al. 2021. Commun Biol. 4:905. PubMed
  151. Dholakia J, et al. 2022. Gynecol Oncol. 164:170. PubMed
  152. Wang Y, et al. 2022. Front Immunol. 13:847581. PubMed
  153. Kronborg Hansen AK, et al. 2022. Int J Mol Sci. 23:. PubMed
  154. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  155. Liu X, et al. 2021. Int J Med Sci. 18:3125. PubMed
  156. Song E, et al. 2020. Nature. 577:689. PubMed
  157. Canedo T, et al. 2021. Neuropsychopharmacology. 46:2358. PubMed
  158. Ma L, et al. 2022. Sci Adv. 8:eabm3470. PubMed
  159. Milon B, et al. 2021. Cell Rep. 36:109758. PubMed
  160. Dieu RS, et al. 2021. Front Neurosci. 15:685645. PubMed
  161. Bao Z, et al. 2020. Ann Transplant. 25:e921287. PubMed
  162. Montel‐Hagen A et al. 2019. Cell stem cell. 24(3):376-389 . PubMed
  163. Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed
  164. Zhang Y, et al. 2021. Commun Biol. 344:4. PubMed
  165. Liao Y, et al. 2020. Theranostics. 7.113888889. PubMed
  166. Watson N, et al. 2015. J Immunol. 194:2796. PubMed
  167. Liu B, et al. 2013. Development. 140:780. PubMed
  168. Wang X, et al. 2021. Inflammation. 44:1815. PubMed
  169. Sanz-Ros J, et al. 2022. Sci Adv. 8:eabq2226. PubMed
  170. Xu L, et al. 2019. Haematologica. 10.3324/haematol.2018.207258. PubMed
  171. Genoud V, et al. 2018. Oncoimmunology. 7:e1501137. PubMed
  172. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  173. Korin B, et al. 2020. Sleep. :43. PubMed
  174. An X, et al. 2020. Thyroid. . PubMed
  175. Bollinger JL, et al. 2020. Neuropsychopharmacology. 45:1766. PubMed
  176. Yue F, et al. 2022. Cell Rep. 38:110267. PubMed
  177. Andreou T, et al. 2021. J Immunother Cancer. 9:. PubMed
  178. Nakao M, et al. 2021. Sci Rep. 11:18384. PubMed
  179. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  180. Orhon I, et al. 2021. Autophagy. :1. PubMed
  181. Szõke D, et al. 2021. Nat Commun. 12:3460. PubMed
  182. Lau A, et al. 2022. Sci Adv. 8:eabm0142. PubMed
  183. Hung G, et al. 2022. NPJ Aging. 8:10. PubMed
  184. Gawish R, et al. 2022. Elife. 11:. PubMed
  185. Wen G, et al. 2018. J Am Heart Assoc. 7:e008187. PubMed
  186. Stone S et al. 2018. Glia. 66(7):1331-1345 . PubMed
  187. Kojima T, et al. 2016. Sci Rep. 6:36457. PubMed
  188. Gardenier J, et al. 2017. Nat Commun. 8:14345. PubMed
  189. Singh K, et al. 2021. Front Immunol. 640837:12. PubMed
  190. Lehmann M, et al. 2020. Cell Signal. 70:109588. PubMed
  191. Cugurra A, et al. 2021. Science. 373:. PubMed
  192. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  193. Lupan AM, et al. 2021. Aging (Albany NY). 13:15875. PubMed
  194. Engelmann R, et al. 2017. J Negat Results Biomed. 16:05. PubMed
  195. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
  196. Lehmann ML, et al. 2018. Sci Rep. 8:11240. PubMed
  197. Li J, et al. 2021. eLife. 10:00. PubMed
  198. Simula L, et al. 2020. Cell Death Differ. 27:2749. PubMed
RRID
AB_312970 (BioLegend Cat. No. 103105)
AB_312970 (BioLegend Cat. No. 103106)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
CD45
Specificity Alt (DOES NOT SHOW ON TDS):
CD45
App Abbreviation (DOES NOT SHOW ON TDS):
FC
UniProt
View information about CD45 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS UV395™ anti-mouse CD45 30-F11 FC
Go To Top Version: 2    Revision Date: 05/14/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account